- Home
- Who we are
- Read, watch, listen
- Pharmacy
- Home Delivery
- Specialty Pharmacy
- Specialty Pharmacy - Patients
- Care Specialists Program
- Education Center
- Hypercholesterolemia
- Solid organ transplant
- Asthma
- Cystic fibrosis
- Hemophilia
- Hepatitis C
- Human Immunodeficiency Virus (HIV)
- Inflammatory bowel disease
- Osteoporosis
- Multiple Sclerosis
- Oncology (cancer)
- Psoriasis and psoriatic arthritis
- Rheumatoid arthritis
- Rights and responsibilities
- Overcome medicine challenges
- Specialty Pharmacy - Providers
- Patient Forms
- Careers
- Benefits
- Hub + Home
- Medication Therapy Management Internship
- Managed Care Residency Program
- Application Process
- Contact Us
- Newsroom Custom Content
- Media
- Prime Careers Spotlight
- 2024
- Prime Careers Spotlight: September 2024
- Prime Careers Spotlight: October 2024
- Prime Careers Spotlight: November 2024
- 2025
- Prime Careers Spotlight: April 2025
- Prime Careers Spotlight: December 2025
- Prime Careers Spotlight: November 2025
- Prime Careers Spotlight: October 2025
- Prime Careers Spotlight: September 2025
- Prime Careers Spotlight: August 2025
- Prime Careers Spotlight: July 2025
- Prime Careers Spotlight: June 2025
- Prime Careers Spotlight: May 2025
- Prime Careers Spotlight: January 2026
- Prime Careers Spotlight: February 2026
- Prime Careers Spotlight: March 2026
- Prime Careers Spotlight: April 2026
- Publications
- Cell & Gene Pipeline Outlook
- Climate change: An imprint on health
- Clinical Highlights
- Clinical Highlights: September 2024
- Clinical Highlights: October 2024
- Clinical Highlights: November 2024
- Clinical Highlights: December 2024
- Clinical Highlights: January 2025
- Clinical Highlights: February 2025
- Clinical Highlights: March 2025
- Clinical Highlights: April 2025
- Clinical Insights
- 2022 Clinical Insights: Therapeutic Psychedlics: An emerging frontier in mental health
- 2022 Clinical Insights: Virtual reality: An emerging paradigm in healthcare
- Summer 2025 Issue: Clinical Insights – MASH
- Clinical News
- Clinical News
- Clinical News: August 2024
- Clinical News: June 2024
- Clinical News: May 2024
- Clinical News: April 2024
- Drug Approvals
- Drug Approvals Monthly Update: August 2024
- Drug Approvals Monthly Update: June 2024
- Drug Approvals Monthly Update: May 2024
- Drug Approvals Monthly Update: April 2024
- Drug Approvals Monthly Update: March 2024
- Drug Approvals Monthly Update: February 2024
- Drug Approvals Monthly Update: January 2024
- Drug Approvals Quarterly Update
- Drug Approvals Monthly Update: September 2024
- Drug Approvals: October 2024
- Drug Approvals: November 2024
- Drug Approvals: December 2024
- Drug Approvals: January 2025
- Drug Approvals: July 2024
- Drug Approvals: February 2025
- Drug Approvals: March 2025
- Drug Approvals: April 2025
- Employer Market Insight Reports
- Expert Clinical Network Insights
- 2024-2025
- Expert Clinical Network Insights: June 2024
- Expert Clinical Network Insights: April 2024
- Expert Clinical Network Insights: October 2024
- Expert Clinical Network Insights: December 2024
- Expert Clinical Network Insights: March 2025
- Expert Clinical Network Insights: August 2025
- Expert Clinical Network Insights: September 2025
- Expert Clinical Network Insights: December 2025
- Expert Clinical Network Insights: January 2026
- Expert Clinical Network Insights: March 2026
- Expert Clinical Network Insights: May 2026
- FDA Decisions Expected
- 2024-2025
- FDA Decisions Expected: October 2024
- FDA Decisions Expected November 2024
- FDA Decisions Expected: December 2024
- FDA Decisions Expected: January 2025
- FDA Decisions Expected: February 2025
- FDA Decisions Expected: March 2025
- FDA Decisions Expected: April 2025
- FDA Decisions Expected: May 2025
- FDA Decisions Expected: June 2025
- FDA Decisions Expected: July 2025
- FDA Decisions Expected: August 2025
- FDA Decisions Expected: September2025
- FDA Decisions Expected: October 2025
- FDA Decisions Expected: November 2025
- FDA Decisions Expected: December 2025
- FDA Decisions Expected: January 2026
- FDA Decisions Expected: February 2026
- FDA Decisions Expected: March 2026
- FDA Decisions Expected: April 2026
- FDA Decisions Expected: May 2026
- FDA Decisions Expected: June 2026
- FDA Decisions Expected: July 2026
- FDA Decisions Expected: August 2026
- FDA Decisions Expected: September 2026
- GLP-1
- 2024-2025
- GLP-1 Pipeline Update: November 2024
- GLP-1 Pipeline Update: November 2025
- The evolution of GLP-1s
- GLP-1 Pipeline Update: February 2025
- GLP-1 Pipeline Update: May 2025
- GLP-1 Pipeline Update: August 2025
- GLP-1 Pipeline Update: February 2026
- GLP-1 Pipeline Update: May 2026
- GLP-1 Pipeline Update: August 2026
- High Cost Therapy Profile
- 2024-2025
- High-Cost Therapy Profile: August 2024
- High-Cost Therapy Profile: June 2024
- High-Cost Therapy Profile: May
- High-Cost Therapy Profile: April
- High-Cost Therapy Profile: March
- High-Cost Therapy Profile: February
- High-Cost Therapy Profile: January
- High-Cost Therapy Profile: September 2024
- HIGH COST THERAPY PROFILE: OCT 2024
- High Cost Therapy Profile: November 2024
- High Cost Therapy Profile: December 2024
- High Cost Therapy Profile: January 2025
- High Cost Therapy Profile: February 2025
- High-Cost Therapy Profile: March 2025
- High Cost Therapy Profile: April 2025
- High-Cost Therapy Profile: May 2025
- High-Cost Therapy Profile: June 2025
- High-Cost Therapy Profile: July 2025
- High-Cost Therapy Profile: August 2025
- High-Cost Therapy Profile: September 2025
- High-Cost Therapy Profile: October 2025
- High-Cost Therapy Profile: November 2025
- High-Cost Therapy Profile: December 2025
- High-Cost Therapy Profile: January 2026
- High-Cost Therapy Profile: February 2026
- High-Cost Therapy Profile: March 2026
- Oncology Insights
- 2024-2025
- Oncology Insights: Transformative treatment for small cell lung cancer
- Oncology Insights: First-in-class bladder cancer therapy and the Bacillus Calmette-Guérin (BCG) shortage
- Oncology Insights: October 2024
- Oncology Insights: December 2024
- Oncology Insights: 2024 Rewind
- Oncology Insights: February 2025
- Oncology Insights: March 2025
- Oncology Insights: April 2025
- Oncology Insights: May 2025
- Oncology Insights: June 2025
- Oncology Insights: July 2025
- Oncology Insights: August 2025
- Oncology Insights: September 2025
- Oncology Insights: October 2025
- Oncology Insights: November 2025
- Oncology Insights: December 2025
- Oncology Insights: January 2026
- Oncology Insights: February 2026
- Oncology Insights: March 2026
- Oncology Insights: April 2026
- Oncology Insights: May 2026
- Oncology Insights: June 2026
- Oncology Insights: July 2026
- Oncology Insights: August 2026
- Pharmacy Trend Reports
- Medicaid Pharmacy Trend Reports
- 2024 Medicaid Pharmacy Trend Report
- 2025 Medicaid Pharmacy Trend Report
- 2026 Medicaid Pharmacy Trend Report
- 2024 Medical Pharmacy Trend Report
- 2025 Medical Pharmacy Trend Report
- 2026 Medical Pharmacy Trend Report Part 1
- 2026 Medical Pharmacy Trend Report Part 2
- Prime Therapeutics Reports
- Fall 2024 Prime Therapeutics Report
- Spring 2024 Prime Therapeutics Report
- Summer 2024 Prime Therapeutics Report
- Spring 2025 Prime Therapeutics Report
- Summer 2025 Prime Therapeutics Report
- Fall 2025 Prime Therapeutics Report
- Spring 2026 Prime Therapeutics Report
- Summer 2026 Prime Therapeutics Report
- Quarterly Drug Approvals
- 2024-2025
- Quarterly Drug Approvals: October 2024
- Quarterly Drug Approvals: January 2025
- Quarterly Drug Approvals: April 2025
- Quarterly Drug Approvals: July 2025
- Quarterly Drug Approvals: October 2025
- Quarterly Drug Approvals: January 2026
- Quarterly Drug Approvals: April 2026
- Quarterly Drug Approvals: July 2026
- Quarterly Drug Pipeline
- 2024-2025
- Quarterly Drug Pipeline: July 2024
- Quarterly Drug Pipeline: April 2024
- Quarterly Drug Pipeline: January 2024
- Quarterly Drug Pipeline Template 2.0
- Quarterly Drug Pipeline: October 2024
- Quarterly Drug Pipeline: January 2025
- Quarterly Drug Pipeline: April 2025
- Quarterly Drug Pipeline: July 2025
- Quarterly Drug Pipeline: October 2025
- Quarterly Drug Pipeline: January 2026
- Quarterly Drug Pipeline: April 2026
- Quarterly Drug Pipeline: July 2026
- Trending Topics & Drug Approvals
- 2024-2025
- Trending Topics & Drug Approvals: May 2025
- Trending Topics & Drug Approvals: June 2025
- Trending Topics & Drug Approvals: July 2025
- Trending Topics & Drug Approvals: August 2025
- Trending Topics & Drug Approvals: September 2025
- Trending Topics & Drug Approvals: November 2025
- Trending Topics & Drug Approvals: December 2025
- Trending Topics & Drug Approvals: January 2026
- Trending Topics & Drug Approvals: February 2026
- Trending Topics & Drug Approvals: March 2026
- Trending Topics & Drug Approvals: April 2026
- Trending Topics & Drug Approvals: May 2026
- Trending Topics & Drug Approvals: June 2026
- Trending Topics & Drug Approvals: July 2026
- Trending Topics & Drug Approvals: August 2026
- Virtual reality: An emerging paradigm in health care
- Weight management: A holistic journey
- Research
- News & Insights
- Press releases
- In the news
- Research & publications
- Cell & Gene Pipeline Outlook
- Clinical Insights
- Drug Approvals
- Employer Market Insights Report
- FDA Decisions Expected
- GLP-1 Pipeline Update
- Medicaid Trend Report
- Medical Pharmacy Trend Report
- Oncology Insights
- Prime Therapeutics Report
- Quarterly Drug Pipeline
- Research posters & abstracts
- Trending Topics & Drug Approvals
- White Papers
- Perspectives
- Stories
- Events
- Compliance / Legal
- Home
- Who we are
- Read, watch, listen
- Pharmacy
- Home Delivery
- Specialty Pharmacy
- Specialty Pharmacy - Patients
- Care Specialists Program
- Education Center
- Hypercholesterolemia
- Solid organ transplant
- Asthma
- Cystic fibrosis
- Hemophilia
- Hepatitis C
- Human Immunodeficiency Virus (HIV)
- Inflammatory bowel disease
- Osteoporosis
- Multiple Sclerosis
- Oncology (cancer)
- Psoriasis and psoriatic arthritis
- Rheumatoid arthritis
- Rights and responsibilities
- Overcome medicine challenges
- Specialty Pharmacy - Providers
- Patient Forms
- Careers
- Benefits
- Hub + Home
- Medication Therapy Management Internship
- Managed Care Residency Program
- Application Process
- Contact Us
- Newsroom Custom Content
- Media
- Prime Careers Spotlight
- 2024
- Prime Careers Spotlight: September 2024
- Prime Careers Spotlight: October 2024
- Prime Careers Spotlight: November 2024
- 2025
- Prime Careers Spotlight: April 2025
- Prime Careers Spotlight: December 2025
- Prime Careers Spotlight: November 2025
- Prime Careers Spotlight: October 2025
- Prime Careers Spotlight: September 2025
- Prime Careers Spotlight: August 2025
- Prime Careers Spotlight: July 2025
- Prime Careers Spotlight: June 2025
- Prime Careers Spotlight: May 2025
- Prime Careers Spotlight: January 2026
- Prime Careers Spotlight: February 2026
- Prime Careers Spotlight: March 2026
- Prime Careers Spotlight: April 2026
- Publications
- Cell & Gene Pipeline Outlook
- Climate change: An imprint on health
- Clinical Highlights
- Clinical Highlights: September 2024
- Clinical Highlights: October 2024
- Clinical Highlights: November 2024
- Clinical Highlights: December 2024
- Clinical Highlights: January 2025
- Clinical Highlights: February 2025
- Clinical Highlights: March 2025
- Clinical Highlights: April 2025
- Clinical Insights
- 2022 Clinical Insights: Therapeutic Psychedlics: An emerging frontier in mental health
- 2022 Clinical Insights: Virtual reality: An emerging paradigm in healthcare
- Summer 2025 Issue: Clinical Insights – MASH
- Clinical News
- Clinical News
- Clinical News: August 2024
- Clinical News: June 2024
- Clinical News: May 2024
- Clinical News: April 2024
- Drug Approvals
- Drug Approvals Monthly Update: August 2024
- Drug Approvals Monthly Update: June 2024
- Drug Approvals Monthly Update: May 2024
- Drug Approvals Monthly Update: April 2024
- Drug Approvals Monthly Update: March 2024
- Drug Approvals Monthly Update: February 2024
- Drug Approvals Monthly Update: January 2024
- Drug Approvals Quarterly Update
- Drug Approvals Monthly Update: September 2024
- Drug Approvals: October 2024
- Drug Approvals: November 2024
- Drug Approvals: December 2024
- Drug Approvals: January 2025
- Drug Approvals: July 2024
- Drug Approvals: February 2025
- Drug Approvals: March 2025
- Drug Approvals: April 2025
- Employer Market Insight Reports
- Expert Clinical Network Insights
- 2024-2025
- Expert Clinical Network Insights: June 2024
- Expert Clinical Network Insights: April 2024
- Expert Clinical Network Insights: October 2024
- Expert Clinical Network Insights: December 2024
- Expert Clinical Network Insights: March 2025
- Expert Clinical Network Insights: August 2025
- Expert Clinical Network Insights: September 2025
- Expert Clinical Network Insights: December 2025
- Expert Clinical Network Insights: January 2026
- Expert Clinical Network Insights: March 2026
- Expert Clinical Network Insights: May 2026
- FDA Decisions Expected
- 2024-2025
- FDA Decisions Expected: October 2024
- FDA Decisions Expected November 2024
- FDA Decisions Expected: December 2024
- FDA Decisions Expected: January 2025
- FDA Decisions Expected: February 2025
- FDA Decisions Expected: March 2025
- FDA Decisions Expected: April 2025
- FDA Decisions Expected: May 2025
- FDA Decisions Expected: June 2025
- FDA Decisions Expected: July 2025
- FDA Decisions Expected: August 2025
- FDA Decisions Expected: September2025
- FDA Decisions Expected: October 2025
- FDA Decisions Expected: November 2025
- FDA Decisions Expected: December 2025
- FDA Decisions Expected: January 2026
- FDA Decisions Expected: February 2026
- FDA Decisions Expected: March 2026
- FDA Decisions Expected: April 2026
- FDA Decisions Expected: May 2026
- FDA Decisions Expected: June 2026
- FDA Decisions Expected: July 2026
- FDA Decisions Expected: August 2026
- FDA Decisions Expected: September 2026
- GLP-1
- 2024-2025
- GLP-1 Pipeline Update: November 2024
- GLP-1 Pipeline Update: November 2025
- The evolution of GLP-1s
- GLP-1 Pipeline Update: February 2025
- GLP-1 Pipeline Update: May 2025
- GLP-1 Pipeline Update: August 2025
- GLP-1 Pipeline Update: February 2026
- GLP-1 Pipeline Update: May 2026
- GLP-1 Pipeline Update: August 2026
- High Cost Therapy Profile
- 2024-2025
- High-Cost Therapy Profile: August 2024
- High-Cost Therapy Profile: June 2024
- High-Cost Therapy Profile: May
- High-Cost Therapy Profile: April
- High-Cost Therapy Profile: March
- High-Cost Therapy Profile: February
- High-Cost Therapy Profile: January
- High-Cost Therapy Profile: September 2024
- HIGH COST THERAPY PROFILE: OCT 2024
- High Cost Therapy Profile: November 2024
- High Cost Therapy Profile: December 2024
- High Cost Therapy Profile: January 2025
- High Cost Therapy Profile: February 2025
- High-Cost Therapy Profile: March 2025
- High Cost Therapy Profile: April 2025
- High-Cost Therapy Profile: May 2025
- High-Cost Therapy Profile: June 2025
- High-Cost Therapy Profile: July 2025
- High-Cost Therapy Profile: August 2025
- High-Cost Therapy Profile: September 2025
- High-Cost Therapy Profile: October 2025
- High-Cost Therapy Profile: November 2025
- High-Cost Therapy Profile: December 2025
- High-Cost Therapy Profile: January 2026
- High-Cost Therapy Profile: February 2026
- High-Cost Therapy Profile: March 2026
- Oncology Insights
- 2024-2025
- Oncology Insights: Transformative treatment for small cell lung cancer
- Oncology Insights: First-in-class bladder cancer therapy and the Bacillus Calmette-Guérin (BCG) shortage
- Oncology Insights: October 2024
- Oncology Insights: December 2024
- Oncology Insights: 2024 Rewind
- Oncology Insights: February 2025
- Oncology Insights: March 2025
- Oncology Insights: April 2025
- Oncology Insights: May 2025
- Oncology Insights: June 2025
- Oncology Insights: July 2025
- Oncology Insights: August 2025
- Oncology Insights: September 2025
- Oncology Insights: October 2025
- Oncology Insights: November 2025
- Oncology Insights: December 2025
- Oncology Insights: January 2026
- Oncology Insights: February 2026
- Oncology Insights: March 2026
- Oncology Insights: April 2026
- Oncology Insights: May 2026
- Oncology Insights: June 2026
- Oncology Insights: July 2026
- Oncology Insights: August 2026
- Pharmacy Trend Reports
- Medicaid Pharmacy Trend Reports
- 2024 Medicaid Pharmacy Trend Report
- 2025 Medicaid Pharmacy Trend Report
- 2026 Medicaid Pharmacy Trend Report
- 2024 Medical Pharmacy Trend Report
- 2025 Medical Pharmacy Trend Report
- 2026 Medical Pharmacy Trend Report Part 1
- 2026 Medical Pharmacy Trend Report Part 2
- Prime Therapeutics Reports
- Fall 2024 Prime Therapeutics Report
- Spring 2024 Prime Therapeutics Report
- Summer 2024 Prime Therapeutics Report
- Spring 2025 Prime Therapeutics Report
- Summer 2025 Prime Therapeutics Report
- Fall 2025 Prime Therapeutics Report
- Spring 2026 Prime Therapeutics Report
- Summer 2026 Prime Therapeutics Report
- Quarterly Drug Approvals
- 2024-2025
- Quarterly Drug Approvals: October 2024
- Quarterly Drug Approvals: January 2025
- Quarterly Drug Approvals: April 2025
- Quarterly Drug Approvals: July 2025
- Quarterly Drug Approvals: October 2025
- Quarterly Drug Approvals: January 2026
- Quarterly Drug Approvals: April 2026
- Quarterly Drug Approvals: July 2026
- Quarterly Drug Pipeline
- 2024-2025
- Quarterly Drug Pipeline: July 2024
- Quarterly Drug Pipeline: April 2024
- Quarterly Drug Pipeline: January 2024
- Quarterly Drug Pipeline Template 2.0
- Quarterly Drug Pipeline: October 2024
- Quarterly Drug Pipeline: January 2025
- Quarterly Drug Pipeline: April 2025
- Quarterly Drug Pipeline: July 2025
- Quarterly Drug Pipeline: October 2025
- Quarterly Drug Pipeline: January 2026
- Quarterly Drug Pipeline: April 2026
- Quarterly Drug Pipeline: July 2026
- Trending Topics & Drug Approvals
- 2024-2025
- Trending Topics & Drug Approvals: May 2025
- Trending Topics & Drug Approvals: June 2025
- Trending Topics & Drug Approvals: July 2025
- Trending Topics & Drug Approvals: August 2025
- Trending Topics & Drug Approvals: September 2025
- Trending Topics & Drug Approvals: November 2025
- Trending Topics & Drug Approvals: December 2025
- Trending Topics & Drug Approvals: January 2026
- Trending Topics & Drug Approvals: February 2026
- Trending Topics & Drug Approvals: March 2026
- Trending Topics & Drug Approvals: April 2026
- Trending Topics & Drug Approvals: May 2026
- Trending Topics & Drug Approvals: June 2026
- Trending Topics & Drug Approvals: July 2026
- Trending Topics & Drug Approvals: August 2026
- Virtual reality: An emerging paradigm in health care
- Weight management: A holistic journey
- Research
- News & Insights
- Press releases
- In the news
- Research & publications
- Cell & Gene Pipeline Outlook
- Clinical Insights
- Drug Approvals
- Employer Market Insights Report
- FDA Decisions Expected
- GLP-1 Pipeline Update
- Medicaid Trend Report
- Medical Pharmacy Trend Report
- Oncology Insights
- Prime Therapeutics Report
- Quarterly Drug Pipeline
- Research posters & abstracts
- Trending Topics & Drug Approvals
- White Papers
- Perspectives
- Stories
- Events
- Compliance / Legal
Healthcare Businesswomen’s Association names Simone Ndujiuba and Jacki Shugart among 2024 Rising Stars
Prime Therapeutics/Magellan Rx’s Director of Clinical Strategy and Innovation Simone Ndujiuba and Senior Program Manager Jacki Shugart honored for female leadership in the health care industry
The Healthcare Businesswomen’s Association (HBA) recently recognized two of Prime Therapeutics/Magellan Rx’s (Prime/MRx) key leaders as 2024 Rising Stars: Simone Ndujiuba, director of clinical strategy and innovation, oncology, and Jacki Shugart, senior program manager.
The annual award honors female employees, nominated by the HBA’s corporate partner companies, in the first 15 to 20 years of their professional careers who contribute significantly to their organization; exemplify leadership; act as a role model and team player; exhibit dedication to the health care industry; and are a true example of top talent.
Simone Ndujiuba, PharmD, BCOP
As a subject matter expert in oncology for Prime/MRx, Simone has implemented a first-of-its-kind Precision Oncology Solution and represented Prime/MRx at several conferences and thought leadership forums. Her efforts have enabled the organization to consistently remain ahead of market shifts through her work related to clinical strategy and innovation, helping Prime/MRx bring unique solutions to health plans, providers and members that will ultimately improve quality of care across the continuum.
“I’m grateful to be honored among this year’s Rising Stars,” Simone said. “When I attended my first HBA Houston Chapter meeting, I was impressed with the dedicated support to professional growth and the camaraderie between members. Through HBA, I’ve continued to sharpen the skills that help me drive affordability and enhance the experience for our customers and providers.”
Jacki Shugart
As senior program manager for Prime/MRx’s Integration Management Office, Jacki drives awareness and accountability throughout the organization as it relates to integration and enterprise initiatives. A results-driven leader, Jacki played a key role in structured program management and process improvement including meaningful changes to executive team reporting.
“Collaborating across departments and navigating the diverse landscape of various teams to foster alignment and drive forward-thinking solutions brings me great satisfaction in my career,” Jacki said. “I look forward to future work with HBA to propel and support more women into leadership roles in the health care realm as women I have worked with have done for me.”
Simone and Jacki will be recognized among other Rising Stars and Luminaries honorees at the annual Woman of the Year luncheon on Friday, May 10, at the New York Marriott Marquis as well as virtually.
About Prime Therapeutics + Magellan Rx
Prime Therapeutics LLC (Prime) is a diversified pharmacy solutions organization. We offer innovative pharmacy benefit management, specialty and medical drug management, and state government solutions to millions of people across the country. At Prime, we’re reimagining pharmacy solutions to provide the care we’d want for our loved ones. We challenge the way it’s always been done to develop intelligently designed solutions that deliver savings, simplicity and support to help people achieve better health. For more information, visit us at PrimeTherapeutics.com or follow us on LinkedIn.
Related Articles
Managed Healthcare Executive: PBMI Innovator Patrick Gleason, Pharm.D.
RealClearHealth: The Question We Should Be Asking About Drug Costs
Managed Healthcare Executive: Zach Jones, Pharm.D. | 2026 MHE Emerging Leaders in Healthcare
Related Articles
Related Articles
Latest News
Prime Therapeutics names Manmohan Mahajan chief financial officer
Mahajan brings more than 20 years of global finance and leadership experience across healthcare, pharmacy and financial services organizations